Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1
about
Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formationThe role of microRNAs in bone remodelingmicroRNA regulation of Wnt signaling pathways in development and diseaseVitamin D and microRNAs in boneThe role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesisThe roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodellingMicroRNAs regulate bone development and regenerationBone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasisVitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblastsDifferentiation of mesenchymal stem cells into cardiomyocytes is regulated by miRNA-1-2 via WNT signaling pathwaylet-7 enhances osteogenesis and bone formation while repressing adipogenesis of human stromal/mesenchymal stem cells by regulating HMGA2.MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis.miR-214 targets ATF4 to inhibit bone formation.Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.Liposomes in tissue engineering and regenerative medicineMicroRNAs involved in bone formation.Differentially expressed microRNAs in chondrocytes from distinct regions of developing human cartilage.Monocyte exosomes stimulate the osteogenic gene expression of mesenchymal stem cellsDevelopmental definition of MSCs: new insights into pending questions.Signature of microRNA expression during osteogenic differentiation of bone marrow MSCs reveals a putative role of miR-335-5p in osteoarthritis.Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients.ACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a.MicroRNA delivery for regenerative medicine.Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.Do epigenetic marks govern bone mass and homeostasis?A regulatory loop containing miR-26a, GSK3β and C/EBPα regulates the osteogenesis of human adipose-derived mesenchymal stem cells.MicroRNAs' Involvement in Osteoarthritis and the Prospects for Treatments.Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: an approach for treating bone disease in diabetesmiR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cellsMicroRNAs and Bone Regeneration.Wnt signaling in bone formation and its therapeutic potential for bone diseases.MicroRNA control of bone formation and homeostasis.Wnt and Wnt inhibitors in bone metastasis.HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV InfectionmiR-203 inhibits the traumatic heterotopic ossification by targeting Runx2.MiR-218 Induces Neuronal Differentiation of ASCs in a Temporally Sequential Manner with Fibroblast Growth Factor by Regulation of the Wnt Signaling PathwayInterleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation.MiRNA expression in the cartilage of patients with osteoarthritis.
P2860
Q26741198-2E4C65F8-6952-47E7-AE1B-66B756308777Q26798172-05EBCA8A-CF06-4AB1-BF9E-4B903C7F0C3AQ26799815-EFDED09C-A355-4C5F-8DC9-BBA7498C7439Q27011654-63855947-E6F6-45F9-A7CF-1A37010ABF83Q27015808-83E96A91-F596-45DA-9A92-6F43C0636FAEQ27691375-389335F5-944D-4978-91AC-775546618BCFQ28073668-7B8151B0-3C0B-477A-ADD7-19FD38E2160FQ28081746-382C141F-4A81-4BF9-B0A7-527AFD5A27B5Q28087442-AE1216F2-F063-48A8-9504-09207D4334B7Q28284541-55BF36D3-3A8F-47CA-A1A7-F010EB35E016Q33654961-B758439D-B034-440C-95E4-16B3B08F25E6Q33788850-EE6BDA51-472D-4657-9E89-9EA5E8643C61Q34233659-11103A6D-C1A8-4622-B334-A8D5CC22E002Q34316430-092F7CB9-6302-462F-8A28-D1A00B1CAF08Q34437672-0FBEC187-C64A-4A28-8333-E9629B34F53CQ34470412-9A256875-332D-408C-A2B3-843756B06E23Q34527129-E20655FA-2AC6-4ECB-8BD9-1FA2E7AEC367Q34990488-FA5CE805-A05B-4F3B-A43E-BC9CF2298626Q34995017-8F92FEC4-C708-4AE5-A10D-3E6CFFB187C7Q35590130-E4B01CA7-B41E-4C4E-AA32-436B8FD808F9Q35737935-594394C2-B38B-4097-9D0E-1F83279272EFQ35767669-B628DA58-C6F0-495E-BDED-6E6B1C470528Q35795849-48331209-29B3-4D6C-8AD5-AD5B50362CEDQ35863950-7E165876-56EC-4B08-8634-EBB58C5CD366Q35928872-BBCB9AE1-7DC9-4C29-85BB-8125591AD6E7Q36055881-F356ECF5-8979-47AF-A957-DBFC5BF98B1CQ36164526-62F77594-EC02-422C-94C3-690F9F68A5E7Q36261112-3FCEC396-CA4B-4E62-9E31-7CD1AEBCD048Q36377482-F9E55F72-F7E3-44F6-9FFD-51926BE6FC01Q36451980-CD0047FE-62CB-4FBB-A66C-C90C2ED482BDQ36613082-CF485D2A-4048-49AE-9626-504996ABD642Q36638647-D6DA6D4F-7681-407A-B28F-13F1081D8D12Q36661323-3699C821-01BA-49C6-9A59-179B3E066F06Q37056355-6C17B433-FE2A-46B6-910C-8448B91D45D9Q37304461-73D2E13A-587A-4280-B41D-DC898F419E6AQ37465938-36C69AB0-A7EC-43F7-B5FA-C053F113BFDFQ37550547-2A40AD5F-B4C2-4E04-ABDA-CF96D9BCF752Q37581596-26CD7967-E17B-4AB4-8741-0CE22CB8B2F4Q37620702-775D3E20-CF6A-440D-BA55-83036D44AF93Q37727019-0836C42D-CBE3-4026-919D-DA005EC69818
P2860
Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of miR-335-5p in modul ...... regulating Wnt antagonist DKK1
@en
Effects of miR-335-5p in modul ...... egulating Wnt antagonist DKK1.
@nl
type
label
Effects of miR-335-5p in modul ...... regulating Wnt antagonist DKK1
@en
Effects of miR-335-5p in modul ...... egulating Wnt antagonist DKK1.
@nl
prefLabel
Effects of miR-335-5p in modul ...... regulating Wnt antagonist DKK1
@en
Effects of miR-335-5p in modul ...... egulating Wnt antagonist DKK1.
@nl
P2093
P2860
P356
P1476
Effects of miR-335-5p in modul ...... regulating Wnt antagonist DKK1
@en
P2093
Gary Stein
Lynda F Bonewald
Qisheng Tu
P2860
P304
P356
10.1002/JBMR.377
P577
2011-08-01T00:00:00Z